Conclusions: In this small, single-center study, a therapeutic response to MMF was obtained only in one third of patients. This response rate, though it is low, encourages us to use MMF in some patients who are resistant to conventional therapy for SRNS.
PMID: 21319130 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)